Abstract
The SARS-CoV-2 virus is still causing a worldwide problem. The virus settles primarily on the nasal mucosa, and the infection and its course depend on individual susceptibility. Our aim was to investigate the nasopharynx composition’s role in the individual susceptibility. During the first phase of SARS-CoV-2 pandemic, nasopharyngeal microbiome samples of close contact unvaccinated patients were investigated by 16S rRNA analysis and by culturing. The whole genome of cultured Corynebacteria was sequenced. The relative expression of ACE2, TMPRSS2, and cathepsin L on Caco-2 cells and the strength of S1-ACE2 binding were determined in the presence of Corynebacteria. From 55 close contacts exposed to identical SARS-CoV-2 exposure, 26 patients became infected and 29 remained uninfected. The nasopharyngeal microbiome analysis showed significantly higher abundance of Corynebacteria in uninfected group. Corynebacterium accolens could be cultivated only from uninfected individuals and Corynebacterium propinquum from both infected and uninfected. Corynebacteria from uninfected patient significantly reduced the ACE2 and cathepsin L expression. C. accolens significantly reduced the TMPRSS2 expression compared to other Corynebacteria. Furthermore, Corynebacterium spp. weakened the binding of the S1-ACE2. Most C. accolens isolates harbored the TAG lipase LipS1 gene. Based on these results, the presence of Corynebacterium spp. in the nasopharyngeal microbiota, especially C. accolens strains, could reduce the individual susceptibility to SARS-CoV-2 infection by several mechanisms: by downregulation the ACE2, the TMPRSS2 receptors, and cathepsin L in the host; through the inhibition of S1-ACE2 binding; and lipase production. These results suggest the use of C. accolens strains as probiotics in the nasopharynx in the future.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Epithelial cells of the upper and lower respiratory tracts are primary targets for airborne infections including SARS-CoV-2. These cells are covered by complex bacterial communities mainly in the upper respiratory tract that may directly or indirectly interact with coronaviruses. The commensal microbiota may also prevent infection by regulating innate and adaptive host immune responses [1]. A relationship was observed between the composition of nasopharyngeal microbiota and individual susceptibility to upper respiratory viral (e.g., influenza) and bacterial infections [2,3,4].
The COVID-19 epidemic is still a serious problem. One of the reasons for this is that the evolution of SARS-CoV-2 has led to the emergence of several new variants. The new variants show distinct cell tropism and mode of entry compared to other SARS-CoV-2 variants. Unlike the original, other SARS-CoV-2 variants can primarily use the cathepsin L entry route in addition to the ACE2 and TMPRSS2 cell entry route [5, 6].
The aim of our study was to investigate the nasopharyngeal microbiota of SARS-CoV-2 infected and close-contact non-infected individuals exposed to identical external environment between May and June 2020, and in November–December 2020 at Semmelweis University. During this period, all subjects in the study were still unvaccinated.
Methods
Ethical approval and involvement of patients in the study, consent to participate
Sample collection protocols were approved by the Ethics Committee of Semmelweis University (SE RKEB: 217/2020) and by National Public Health Center (38215-6/2020 EÜIG). The present study was conducted in accordance with ethical standards that promote and ensure respect and integrity for all human subjects and the Declaration of Helsinki. We state that no sex-based or race/ethnicity-based differences were present. All research was performed in accordance with guideline and regulation of Semmelweis University. Written informed consent has been obtained from the participants (or their legal guardians) of the study before sampling.
In the periods between May and June 2020 in a closed community during a local epidemic of SARS-CoV-2 and between November and December 2020, longitudinal household transmissions were analyzed at Semmelweis University, in 2 waves of the COVID-19 epidemic in Hungary. Nasopharyngeal swab samples were collected from 27 inpatients and 28 outpatients, respectively. Of the subjects included in the study, 26 had symptomatic and PCR-confirmed SARS-CoV-2 infection. The selection criteria for the negative control group (29 persons) were close contact with infected subjects, multiple PCR-negative results during the study period, no symptoms, no vaccination, and no previous evidence of COVID-19 infection verified with negative AdviseDx SARS-CoV-2 IgG II CMIA test (Abbott, USA). A patient was considered negative if the person had a negative PCR and serological test. A patient was considered positive with a positive PCR test. Patients with positive serological test, but negative PCR test were ruled out of the study.
Culture methods
Nasopharyngeal swab samples of the second study group patients were inoculated on Columbia blood agar (Biolab, Hungary). Antimicrobial susceptibility disk containing 50 µg fosfomycin (Oxoid, Sweden) was used to select Corynebacterium strains from other bacterial participants. All cultured bacteria were identified by MALDI-TOF (Bruker Daltonik, Germany).
For the detection of bacterial products that affect the ACE2-spike binding, 24 different Corynebacterium strains previously isolated from the second study group patients’ nasopharyngeal swabs were cultured in EMEM medium (Lonza Bioscience, USA) at 37 °C in an atmosphere containing 5% CO2.
The human colonic epithelial cell line Caco-2 (Sigma-Aldrich, USA) was cultured in EMEM medium at 37 °C in a humidified atmosphere containing 5% CO2 and the medium was changed every 2 days. No antibiotics were added to allow the co-cultivation of bacteria. The Caco-2 cells were cultivated alone for 4 days before the addition of the overnight cultures of Corynebacteria. Human Caco-2 cells and bacteria were co-cultured for additional 24 h.
We examined how each Corynebacterium strain and the two Streptococcus strains—one Streptococcus mitis and one Streptococcus sanguis—mutually influence reproduction. A pure bacterial culture from each bacterial strain was suspended in saline, its turbidity was standardized at 0.5 McFarland, and it was swabbed uniformly across Columbia blood agar plates forming a basic lawn. All Corynebacterium strain lines were grafted onto both Streptococcus lawns and, conversely, the two Streptococcus strains were grafted onto each Corynebacterium lawn. The inhibitory effect of lawns on the growth of the lines was investigated.
DNA isolation, 16S rRNA gene library preparation, and MiSeq sequencing
DNA isolation was performed according to manufacturer’s protocol by the ZymoBIOMICS DNA Miniprep Kit (Zymo Research Corp, USA). Isolated DNA samples were placed at − 80 °C until PCR amplification. Concentration of genomic DNA was measured using a Qubit2.0 Fluorometer with Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific, USA). Bacterial DNA was amplified with tagged primers covering the V3-V4 region of bacterial 16S rRNA gene. PCR and DNA purification were performed according to Illumina’s protocol. PCR product libraries were assessed using the DNA 1000 Kit with Agilent 2100 Bioanalyzer (Agilent Technologies, Germany). Equimolar concentrations of libraries were pooled and sequenced on the Illumina MiSeq platform (Illumina, USA), using MiSeq Reagent Kit v3 (600 cycles PE).
In order to evaluate the contribution of extraneous DNA from reagents, extraction negative controls and PCR negative controls were included in every run. To ensure reproducibility, each sample was independently extracted and sequenced twice.
Raw sequencing data were retrieved from the Illumina BaseSpace and uploaded to the CosmosID Bioinformatics Platform for evaluation (CosmosID Metagenomics Cloud, app.cosmosid.com, CosmosID Inc., www.cosmosid.com).
Whole genome sequencing
From 22 Corynebacterium strains, genomic DNA were isolated using the NucleoSpin Microbial DNA Kit (Macherey Nagel, Germany). The NGS libraries in both cases were prepared using the Nextera DNA Flex Library Prep Kit according to the manufacturer’s instructions (Illumina, USA). The libraries were paired-end sequenced on a MiSeq instrument using 250 bp read length (MiSeq Reagent Kit v2, 500-cycles). The fastq files were used to assemble the de novo draft genome sequence using the SPAdes de novo genome assembler (version 3.7.1) and the BioNumerics version 7.6 software (Applied Maths NV, Belgium).
ACE2-spike binding inhibition
Twenty-four broth cultures of different bacterial strains were centrifuged at 8000 g for 3 min and the cell free supernatants were tested with the Cayman Chemical (Cayman Chemical Company, USA) SARS-CoV-2 spike-ACE2 interaction screening assay kit, according to the manufacturer’s instructions. Briefly, the assay uses a recombinant rabbit Fc-tagged SARS-CoV-2 spike S1 RBD attached to the plate precoated with a mouse anti-rabbit antibody. Fifty microliters of supernatant was used to test competition of RBD-ACE2 interaction. The test uses recombinant His-tagged ACE2 protein, HRP conjugated anti-His antibody, and TMB substrate. Results were read at 450-nm wavelength. All samples were assayed in triplicate. The mean OD of the inhibition control reagent included in the kit was considered to induce 0% binding activity, and the mean OD of sterile broth medium was considered as 100% of the initial activity.
Examination of ACE2, TMPRSS2, and cathepsin L expression of Caco-2 cells after bacterial co-culture
Caco-2 cells were cultivated for 4 days, an overnight culture of Corynebacteria was added to the Caco-2 cell lines, and for 24 h were further co-cultivated. The cells were washed by PBS and 0.25% trypsin and centrifuged. The total RNA was isolated by innuPREP RNA Mini Kit 2.0 (Analytik Jena GmbH, Germany) according to manufacturer’s instructions. RNA concentrations were determined using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, USA). Ten to 100 ng of RNA was used for RT-PCR assay performed using the PrimeScript RT reagent kit (Takara Bio, USA) and amplified the resulting cDNA on a qTOWER 3G (Analytik Jena GmbH, Germany) instrument in the presence of selected primers.
The primers for ACE2 were 5′-GGG ATC AGA GAT CGG AAG AAG AAA-3′ forward and 5′-AGG AGG TCT GAA CAT CAT CAG TG-3′ reverse. The primers for TMPRSS2 were 5′-AAT CGG TGT GTT CGC CTC TAC-3′ forward and 5′-CGT AGT TCT CGT TCC AGT CGT-3′ reverse. The primers for cathepsin L were 5′-CTG GTG GTT GGC TAC GGA TT-3′, CTSL forward and 5′-CTC CGG TCT TTG GCC ATC TT-3′ reverse. The primers for GAPDH were 5′-CTA CTG GCG CTG GCA AGG CTG T-3′ forward and 5′-GCC ATG AGG TCC ACC ACC CTG CTG-3′ reverse.
Relative mRNA expression was calculated by means of the change in cycle threshold (ΔΔCt) and normalized to the geometric mean of housekeeping genes GAPDH. Basal mRNA levels of ACE2 and TMPRSS2 were compared with those of housekeeping gene GAPDH by calculating the difference between their Ct. All experiments were performed four times.
Data availability
The metagenomics datasets generated during the current study are deposited in the NCBI Short Read Archive (SRA) (https://www.ncbi.nlm.nih.gov/sra) under accession numbers PRJNA728384 and PRJNA842591. The WGS of the selected Corynebacteria spp. are available in the PRJNA842591 Bioproject under Biosample SAMN28690426–SAMN28690445 numbers.
Statistical analysis
Patient groups were compared with a two-sided t-test for independent groups in case of age and were compared with Mann-Whitney U test in case of gender, smoking status, underlying diseases, and previous antibiotic treatment.
The significance of the difference between relative abundance of taxon levels was calculated with the Mann-Whitney-Wilcoxon test. For analyzing the difference between the OD levels in ACE2-spike binding inhibition ELISA test, two-tailed Student’s t-test was used. In ACE2 and TMPRSS2 expression studies, the difference between mRNA levels measured in the different bacterial co-culture groups was calculated by two-tailed Student’s t-test. Statistical significance between cohorts was implemented using CHAO1, Simpson, and Shannon index for microbiome alpha diversity and Jaccard or by Bay-Curtis test for beta diversity.
Results
Patients involved in the study, description of the virus exposition
The first study was completed between May and June 2020 in a closed community during a local epidemic of SARS-CoV-2 at the Department of Psychiatry and Psychotherapy at Semmelweis University. A patient admitted for acute psychiatric illness was found to be COVID positive after admission to the psychiatric ward. Given that the psychiatric patients in this closed community were not suitable for contact isolation due to their mental illness, they acquired the infection from the index COVID patient or from their already infected fellow patients. Despite this, of the 27 patients in close contact with each other in the secure psychiatric ward, 16 patients became infected with the SARS-CoV-2 virus (13 men and 3 women), and the remaining 11 patients were not infected with the virus. During the observed 1.5-month period, the average number of PCR tests performed per patient was 13, with a minimum of 7 and a maximum of 18 SARS-CoV-2 PCR tests per patient from the nasopharyngeal samples.
The second study analyzed longitudinal household transmissions between November and December 2020 at Semmelweis University. In these cases, a member of the family was forced to self-quarantine due to their COVID-positivity along with family members living in the same household. Family members shared a common dining room, bedroom, and restroom. Several of the people living in joint quarantine were infected with the SARS-CoV-2 virus, but some were not. Ten SARS-CoV-2 positive individuals and their family members, eighteen individuals were quarantined together.
Altogether, from the total 55 persons being close contacts, 26 patients became infected, while 29 persons remained uninfected despite identical virus exposure.
A total of 55 patients were enrolled in the study. Baseline demographics were overall well balanced, the mean age was 44 years, 58% of the study population were male, 62% of patients were non-smokers, 29% of the patients had underlying diseases, and 11% received antibiotic treatment in the last 3 months. However, significant difference was observed in terms of gender; significantly (p < 0.001) more men were infected with the SARS-CoV-2 virus. However, there were no significant differences observed in the other parameters: age, smoking, underlying diseases, previous antibiotic treatment among the patients in the SARS-CoV-2 positive and SARS-CoV-2 negative groups. The baseline characteristics—age, gender, smoking, underlying diseases, and previous antibiotic treatment—of the patients involved in the studies are summarized in Table 1.
Nasopharyngeal microbiome analysis
The overall nasopharyngeal microbiota composition was different between the 26 SARS-CoV-2 positive and 29 SARS-CoV-2 close contact negative subjects in alpha diversity. The alpha diversity indexes were higher in positive patients and lower in negative close contact persons with significant difference in alpha diversity by CHAO1 (p = 0.031) 535 [576–455] vs 429 [528–344] (Fig. 1). There were no significant differences in alpha diversity calculated by the Simpson index (p = 0.125) 0.8 [0.9–0.7] vs 0.85 [0.9–0.75] and the Shannon index (p = 0.206) 4.29 [3.4–4.8] vs 3.7 [3.1–4.3] (Fig. 1a). The beta diversity analysis showed no significant clustering either by Jaccard or by Bay-Curtis analysis.
The taxonomic analysis of the nasopharyngeal microbiome by 16S rRNA showed at phylum level higher amounts of Firmicutes (mean 40.75% vs 38.32%) and marked less Actinobacteria (mean 28.99% vs 40.81%) in SARS-CoV-2 positive patients with no significant differences. At family level and in SARS-CoV-2 negative individuals, the abundance of Corynebacteriaceae and Streptococcaceae was significantly different (p < 0.05) (Fig. 1b). The heatmap of the individual nasopharyngeal microbiome at genus level showed Staphylococcus, Corynebacterium, and Streptococcus dominated microbiome (Fig. 1c). At the genus level, the abundance of Corynebacterium spp. was significantly increased (mean value 34.82% vs 20.82%, p < 0.05), and the abundance of Streptococcus spp. significantly decreased (mean 8.63% vs 1.63%, p < 0.05) in the close contact negative uninfected group compared to positive infected group (Fig. 1d). No significant difference was observed regarding the abundance of Staphylococci.
Nasopharyngeal culture analysis
Nasopharyngeal samples of 10 SARS-CoV-2 positive patients and 18 negative close contact family members were conventionally cultured during the second study period.
The positive patients exhibited in four cases Corynebacterium propinquum, and in all the cases one or more different Streptococcus spp. (S. mitis, S. sanquis, S. salivarus, S. pneumoniae, S. pseudopneumoniae, S. oralis, S. agalactiae) strains. Additionally, in four cases Staphylococcus epidermidis and in three cases Moraxella nonliquefaciens, Citrobacter koseri, and Klebsiella pneumoniae were cultured.
In contrast, either pure culture of Corynebacterium, Corynebacterium tuberculostearicum, and Corynebacterium pseudodiphtericum were cultivated from the nasopharyngeal samples of SARS-CoV-2 negative close contacts, or these bacteria have been associated with C. propinquum or other bacteria including Staphylococcus aureus and S. epidermidis.
Altogether from the negative close contact uninfected individuals, nine C. accolens, one C. tuberculostearicum, one C. pseudodiphtericum, and seven C. propinquum strains were isolated. From the nasopharyngeal samples of SARS-CoV-2 positive patients, only four C. propinquum strains were observed (Table 2).
Whole-genome sequence analysis of the Corynebacteria
All the 22 Corynebacterium spp. were sequenced. The TAG lipase LipS1 production in eight of nine C. accolens strains was confirmed by screening the whole-genome sequence. None of the other Corynebacterium spp. harbored the lipase gene (Table 2).
Mutual cross influence of Corynebacterium spp. and Streptococcus spp. on each other growth
All isolated Corynebacteria’s growth were tested in the presence of one-one randomly selected S. mitis and S. sanguis strains from infected patients. All 22 Corynebacterium spp. except one C. accolens were able to grow in the presence of S. sanguis; however, the presence of S. mitis inhibited the growth of three C. accolens strains and one C. propinquum strain. Some strains of Corynebacteria could inhibit the growth of S. mitis (3 of 22) and S. sanguis (2 of 22) indicating a competition in mixed culture settings (Table 2).
The effect of Corynebacterium spp. on the ACE2, TMPRSS2, and cathepsin L expression in human cells
Subsequently, nine C. accolens, one C. tuberculostearicum, one C. pseudodiphtericum, and seven C. propinquum strains isolated from negative close contacts were further examined. Additionally, four C. propinquum strains from positive patients were enrolled in a comprehensive in vitro study.
Significant difference (p < 0.001) was observed in ACE2 receptor downregulation among Corynebacterium strains isolated from close contact negative patients and the Corynebacteria isolated from SARS-CoV-2 infected positive patients (Fig. 2a). However, no significant difference was observed between the accolens group (C. accolens and C. tuberculostearicum) and the propinquum group (C. propinquum and C. pseudodiphtericum) in reducing ACE2 relative expression.
All Corynebacterium spp. decreased the relative expression of TMPRSS2 showing significant difference (p < 0.05) between the accolens group—C. accolens and C. tuberculostearicum—and propinquum group—C. pseudotuberculosis and C. propinquum (Fig. 2b). However, no significant differences were observed between the Corynebacteria isolated from SARS-CoV-2 positive or close contact negative patients.
There were significant differences (p < 0.01) observed in cathepsin L downregulation between Corynebacteria isolated from close contact negative patients and the cathepsin L expression-reducing effect of Corynebacteria isolated from SARS-CoV-2 positive patients (Fig. 2c). But there were no significant differences between the accolens group—C. accolens and C. tuberculostearicum—and propinquum group—C. pseudotuberculosis and C. propinquum.
Effects of isolated Corynebacterium spp. on the binding strength of S1 protein and ACE2
By examining the supernatants of all isolated Corynebacterium spp. for the strength of S1 protein ACE2 binding, we observed that all Corynebacterium spp. strains weakened the binding of S1 protein to the ACE2 receptor. However, there was no significant differences observed neither between the positive and close contact infected patients groups, nor between the accolens and propinquum groups (Fig. 2d).
Discussion
The correlation of the healthy state of the nasopharyngeal commensal microbiome and infections by SARS-CoV-2 viruses has also been raised recently in several studies, but it has not been clarified until now [7,8,9,10,11].
Even some authors found that SARS-CoV-2 infection does not significantly alter the composition of the microbiome [12], others reported based on 16S rRNA analysis that some Corynebacteria strains were more abundant in SARS-CoV-2 negative subjects, and others were more abundant in those infected with the virus [13]. Shilts et al. found that the relative abundance of an unclassified Corynebacterium consistently decreased as COVID-19 severity increased [14]. By metagenomic next-generation study—capable to species based identification in contrast to 16S rRNA analysis—Kumpitsch et al. [6] reported a statistically significant decrease of incidence of a commensal organism, C. accolens, in the samples of COVID-19-positive patients.
Our study also confirmed that close contact uninfected individuals showed significantly higher levels of Corynebacterium genus based on 16S rRNA analysis and in addition less abundant Streptococcus genus in their nasopharyngeal microbiome. By conventional culturing, C. accolens species often appeared in pure culture of in SARSCoV-2 negative close contacts, but was not cultured from any SARS-CoV-2 positive patients.
In SARS-CoV-2 infection, the role of the gut microbiome has been studied more widely; it has already been described that Bacteroides dorei, Bacteroides thetaiotaomicron, Bacteroides massiliensis, and Bacteroides ovatus downregulate expression of ACE2 receptors in the gut [15], and furthermore Akkermansia muciniphila and Faecalibacterium prausnitzii treatments appear to decrease the expression levels of cathepsin L [16]. The correlation between the abundance of several members of the genus Streptococcus and systemic inflammatory markers in SARS-CoV-2 infection was observed in the gut microbiome as well [17].
To the best of our knowledge, our study is the first to examine the role of human nasopharyngeal microbiota in regulating the expression of ACE2, TMPRSS2, and cathepsin L the entry gates of the SARS-CoV-2 virus. Based on our results, C. accolens and some defined C. propinquum strains significantly reduced the expression of ACE2, TMPRSS2, and cathepsin L, all of which are essential for adherence of the virus to cells [18]. The ACE2 receptor is essential for the attachment of the SARS-CoV-2 virus to the cell surface, but it depends on the SARS-CoV-2 mutants whether it enters the cell by membrane fusion with the TMPRSS2 receptor, for example, beta variant, or by endocytosis with the cathepsin L, for example, omicron variant. C. accolens inhibits both cell entry pathways, so its protective effect is mutant-independent. Furthermore, compounds produced by some Corynebacterium strains weakened the strength of binding between the SARS-CoV-2 spike protein and ACE2 receptor.
TAG lipase LipS1 produced by C. accolens is likely to be extracellular [19] and we assume that it could hydrolyze the coronavirus envelope as well. Furthermore, TAG lipase LipS1 releases oleic acid from oleoylethanolamide through triolein hydrolysis, and thus inhibits the release of proinflammatory cytokines induced by SARS-CoV-2 [20].
Corynebacterium and Streptococcus strains are often involved in the formation of the normal nasopharyngeal microbiota and Corynebacterium is associated with a healthy state [21, 22]. Our results indicate that individual susceptibility to SARS-CoV-2 infection is associated with differences in the overall nasopharyngeal bacterial community structure. It appears that Corynebacterium spp. have a major role in the prevention of infection and these bacteria decrease the infection rate via multiple mechanisms.
In conclusion, presence of Corynebacterium spp. in the nasopharyngeal microbiota, especially C. accolens strains, could reduce the individual susceptibility to SARS-CoV-2 infection by several mechanisms including downregulation (1) the ACE2 and (2) the TMPRSS2 receptors of SARS-CoV-2; and SARS-CoV-2 endocytosis by (3) downregulation cathepsin L expression; (4) through the inhibition of S1 protein—ACE2 receptor binding; and (5) through TAG lipase production. These mechanisms together act by inhibiting the binding and the entry of SARS-CoV-2 to the host cell and by acting on the lipid envelope of the SARS-CoV-2 virus (Fig. 3).
These features definitely provide an advantage to the host against the virus and correlate well with the finding of the greater relative abundance of nasal Corynebacterium spp. in individuals who remain free of infection.
A subset of Corynebacterium spp. as a probiotic in the nasal cavity may be a protective gatekeeper for SARS-CoV-2 and a potential candidate to prevent infection or asymptomatic transmission of coronavirus and other lipid-enveloped respiratory viruses.
A limitation of the current study is the low number of patients. However, here we presented a unique study investigating unvaccinated close contacts individuals, persons involved in the same viral exposure.
References
Pišlar A, Mitrović A, Sabotič J, Pečar Fonović U, Perišić Nanut M, Jakoš T, et al. The role of cysteine peptidases in coronavirus cell entry and replication: the therapeutic potential of cathepsin inhibitors. PLoS Pathog. 2020;16(11):e1009013. https://doi.org/10.1371/journal.ppat.1009013.
Ding T, Song T, Zhou B, Geber A, Ma Y, Zhang L, et al. Microbial composition of the human nasopharynx varies according to influenza virus type and vaccination status. mBio. 2019;10(4):e01296-1. https://doi.org/10.1128/mBio.01296-19.
Tozzi AE, Del Chierico F, Pandolfi E, Reddel S, Gesualdo F, Gardini S, et al. Nasopharyngeal microbiota in hospitalized children with Bordetella pertussis and Rhinovirus infection. Sci Rep. 2021;11(1):22858. https://doi.org/10.1038/s41598-021-02322-y.
Mostafa HH, Fissel JA, Fanelli B, Bergman Y, Gniazdowski V, Dadlani M, et al. Metagenomic next-generation sequencing of nasopharyngeal specimens collected from confirmed and suspect COVID-19 patients. mBio. 2020;11(6):e01969-20. https://doi.org/10.1128/mBio.01969-20.
Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3–20. https://doi.org/10.1038/s41580-021-00418-x.
Kumpitsch C, Koskinen K, Schöpf V, Moissl-Eichinger C. The microbiome of the upper respiratory tract in health and disease. BMC Biol. 2019;17(1):87. https://doi.org/10.1186/s12915-019-0703-z.
Gaibani P, Viciani E, Bartoletti M, Lewis RE, Tonetti T, Lombardo D, et al. The lower respiratory tract microbiome of critically ill patients with COVID-19. Sci Rep. 2021;11(1):10103. https://doi.org/10.1038/s41598-021-89516-6.
Braun T, Halevi S, Hadar R, Efroni G, Glick Saar E, Keller N, et al. SARS-CoV2 does not have a strong effect on the nasopharyngeal microbial composition. Sci Rep. 2021;11(1):8922. https://doi.org/10.1038/s41598-021-88536-6.
Velmurugan G, Vasudevan D. Metagenomic analysis of RNA sequencing data reveals SARS-CoV2-mediated progressive dysbiosis of upper respiratory tract microbiota. Biomed J. 2021;44(4):504–7. https://doi.org/10.1016/j.bj.2021.02.008.
Merenstein C, Liang G, Whiteside SA, Cobián-Güemes AG, Merlino MS, Taylor LJ, et al. Signatures of COVID-19 severity and immune response in the respiratory tract microbiome. mBio. 2021;12(4):e0177721. https://doi.org/10.1128/mBio.01777-21.
Nardelli C, Gentile I, Setaro M, Di Domenico C, Pinchera B, Buonomo AR, et al. Nasopharyngeal microbiome signature in COVID-19 positive patients: can we definitively get a role to Fusobacterium periodonticum? Front Cell Infect Microbiol. 2021;11:625581. https://doi.org/10.3389/fcimb.2021.625581.
De Maio F, Posteraro B, Ponziani FR, Cattani P, Gasbarrini A, Sanguinetti M. Nasopharyngeal microbiota profiling of SARS-CoV2 infected patients. Biol Proced Online. 2020;22:18. https://doi.org/10.1186/s12575-020-00131-7.
Rosas-Salazar C, Kimura KS, Shilts MH, Strickland BA, Freeman MH, Wessinger BC, et al. SARS-CoV2 infection and viral load are associated with the upper respiratory tract microbiome. J Allergy Clin Immunol. 2021;147(4):1226-1233.e2. https://doi.org/10.1016/j.jaci.2021.02.001.
Shilts MH, Rosas-Salazar C, Strickland BA, Kimura KS, Asad M, Sehanobish E, et al. Severe COVID-19 is associated with an altered upper respiratory tract microbiome. Front Cell Infect Microbiol. 2022;11:781968. https://doi.org/10.3389/fcimb.2021.781968.
Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944-955.e8. https://doi.org/10.1053/j.gastro.2020.05.048.
Byeon HR, Jang SY, Lee Y, Kim D, Hong MG, Lee D, et al. New strains of Akkermansia muciniphila and Faecalibacterium prausnitzii are effective for improving the muscle strength of mice with immobilization-induced muscular atrophy. J Med Food. 2022;25(6):565–75. https://doi.org/10.1089/jmf.2021.K.0148.
Sokol H, Contreras V, Maisonnasse P, Desmons A, Delache B, Sencio V, et al. SARS-CoV2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota. Gut Microbes. 2021;13(1):1–19. https://doi.org/10.1080/19490976.2021.1893113.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052.
Bomar L, Brugger SD, Yost BH, Davies SS, Lemon KP. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio. 2016;7(1):e01725-15. https://doi.org/10.1128/mBio.01725-15.
Ghaffari S, Roshanravan N, Tutunchi H, Ostadrahimi A, Pouraghaei M, Kafil B. Oleoylethanolamide, a bioactive lipid amide, as a promising treatment strategy for coronavirus/COVID-19. Arch Med Res. 2020;51(5):464–7. https://doi.org/10.1016/j.arcmed.2020.04.006.
Treerat P, Redanz U, Redanz S, Giacaman RA, Merritt J, Kreth J. Synergism between Corynebacterium and Streptococcus sanguinis reveals new interactions between oral commensals. ISME J. 2020;14(5):1154–69. https://doi.org/10.1038/s41396-020-0598-2.
Man WH, de Steenhuijsen Piters WA, Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15(5):259–70. https://doi.org/10.1038/nrmicro.2017.14.
Funding
Open access funding provided by Semmelweis University. This study was supported by Semmelweis Scientific Innovation Fund (STIA) 2020 and STIA 2021 grant from the Semmelweis University, and by Semmelweis University-Eötvös Lóránd Research Network, Human Microbiota Study Group No “0272” and by the European Union’s Horizon 2020 research and innovation program (952491-AmReSu).
Author information
Authors and Affiliations
Contributions
D.S. and E.O. planned, performed the experiments and analyzed the sequencing data with help from B.S., N.M., and K.P., and performed the 16S rRNA microbiome sequencing. I.A. and K.K. contributed to data interpretation. D.S., E.O., and L.T. designed the study and contributed to experimental design and planning. D.S. and E.O. interpreted the data and wrote the manuscript. J.M.R., R.I.Z., E.B., and B.M. contributed materials/analysis tools and revised the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Szabo, D., Ostorhazi, E., Stercz, B. et al. Specific nasopharyngeal Corynebacterium strains serve as gatekeepers against SARS-CoV-2 infection. GeroScience 45, 2927–2938 (2023). https://doi.org/10.1007/s11357-023-00850-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-023-00850-1